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Chronic kidney disease leads to the development of progressive and 
severe atherosclerosis, ischemic vascular disease, and cardiovascular 
death (1). The terminal stage of chronic kidney disease, classified 
as kidney failure, is treated using renal function replacement 
(hemodialysis, peritoneal dialysis, or kidney transplantation) (2,3). 
During hemodialysis, leukocytes are activated on the dialyzer 
membrane surface resulting in an inflammatory reaction and the 
generation of reactive oxygen species (ROS) (4), which impairs the 
function of tissues and cells, including leukocytes themselves. In 
addition, uremic toxins present at high concentrations in patients 
undergoing hemodialysis give rise to pro-inflammatory and pro-
oxidant states (5). Uncontrolled ROS production that overwhelms 
antioxidant production and disrupts the homeostatic balance 
between oxidants and antioxidants is called oxidative stress. 
This stressed condition damages cellular components, proteins, 
lipids, and DNA and, ultimately, cell integrity (6). In contrast to 
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acid levels.
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their unfavorable effects, ROS also participate in modulating 
antioxidant gene expression and cellular signaling pathways (7,8). 
By activating redox-sensitive transcription factors, ROS enhance 
gene expression of Cu/Zn superoxide dismutase (SOD), Mn SOD, 
glutathione peroxidase (GPx), and catalase in epithelial cells and 
leucocytes (8,9). The superoxide anion radical (O2.-) is an extremely 
reactive substrate of SOD isoenzymes. If not scavenged properly, 
it causes lipid peroxidation (9). Malondialdehyde is a component 
of thiobarbiturate acid-reactive substances (TBARS) and the final 
product of lipid peroxidation. Malondialdehyde is an indicator 
of lipid oxidative damage in membranes of patients undergoing 
hemodialysis (10). In addition to enzymatic antioxidant protection 
comprised of SODs, GPx, and catalase, non-enzymatic antioxidant 
protection plays a very important role neutralizing ROS in cells and 
blood. Total antioxidant status (TAS) is a term that encompasses 
all non-enzymatic antioxidant molecules in the blood, such as 
proteins, urea, creatinine, bilirubin, uric acid, vitamin C, vitamin 
E, reduced glutathione, lipoic acid, β-carotene, and others (11). 
The antioxidant effects of these molecules are additive and they 
exert a significant role scavenging ROS in patients undergoing 
hemodialysis. As a consequence, TAS decreases, not only because 
of its consumption but also due to loss through the dialysis 
membrane. The aim of this study was to determine the influence of 
oxidative stress, antioxidative defense, and inflammatory states in 
the blood on SOD isoenzyme gene expression in peripheral blood 
mononuclear cells of patients undergoing hemodialysis.
MATERIALS AND METHODS
Thirty-three patients (19 males and 14 females; mean age, 55 years) 
with chronic kidney disease receiving hemodialysis were included 
in the study. The diagnoses were as follows: six patients had 
chronic glomerulonephritis, six had nephroangiosclerosis, four had 
chronic renal insufficiency, three had uric acid nephropathies, three 
had Good-Pasture syndrome, two had renal calculosis, two had 
vesicoureteral reflux, one had hypertension, one had atrophia renis 
segmentalis, one had lupus nephritis, one had endemic nephropathy, 
one had chronic pyelonephritis, one had renal tuberculosis, and one 
had renal vasculitis. Because their kidneys were unable to perform 
physiological roles, hemodialysis was substituted. Cessation of 
basic kidney functions and the hemodialysis process itself increases 
oxidative stress (4,5), and, accordingly, all patients were analyzed 
together. The patients had been on hemodialysis ranging from 3 
to 248 days. All patients undergoing hemodialysis were recruited 
from the nephrology clinic.
The control group was comprised of 33 healthy subjects (15 males 
and 18 females; mean age, 45 years). Inclusion criteria for the 
control group were the absence of a family history of cardiovascular 
disease, absence of hypertension (systolic blood pressure <140 
mm Hg and/or diastolic blood pressure <90 mm Hg), (12) and/
or the absence of any antihypertensive therapy, a favorable lipid 
profile according to Adult Treatment Panel III guidelines (13), 
and glucose <6.1 mmol/L. All participants were informed about 
the goals, procedures, and risks of participating in the study. They 
gave their consent for voluntary participation. The local Ethics 
Committee approved this study protocol. This research was carried 
out in compliance with the Declaration of Helsinki. After a 12 hour 
overnight fast, three blood samples were taken from the cubital 
vein using two Vacutainer systems with ethylenediaminetetraacetic 
acid as the anticoagulant to extract plasma and peripheral blood 
mononuclear cells and one Vacutainer had a serum separator gel for 
serum. Plasma and serum were collected by centrifugation for 10 
min at 3.000 rpm, divided into aliquots, and stored at -80 °C until 
analysis, except for the determination of plasma O2.- which was 
performed immediately. Peripheral blood mononuclear cells were 
suspended in 1 mL of TRIzolTM (Invitrogen Life Technologies, 
Foster City, CA, USA) reagent and frozen at -80 °C until total 
RNA isolation. Glucose, total cholesterol, high-density lipoprotein 
cholesterol (HDL-c), low-density lipoprotein cholesterol (LDL-c), 
triglycerides, total protein, urea, and creatinine were measured 
by routine enzymatic methods in plasma using the ILab 300+ 
analyzer (Instrumentation Laboratory, Milan, Italy) and Randox 
Laboratories reagents (Ardmore, UK). High sensitivity C-reactive 
protein (hsCRP) was determined by an immunoturbidimetric 
method using a COBAS® c6000-Roche Diagnostics (Roche, 
Mannheim, Germany) analyzer. 
Thiobarbituric acid-reacting substances (TBARS) were 
measured as the quantity of malondialdehyde-TBA 1:2 adducts 
spectrophotometrically at 535 nm (14). The rate of nitroblue 
tetrazolium reduction was used to measure O2.-
 (15). TAS 
was measured based on decolorization of the 2.2’-azinobis 
(3-ethylbenzothiazoline-6-sulfonic acid) radical cation (16). Total 
RNA was isolated using TRIzolTM reagent according to an optimized 
procedure (17,18). The concentration, purity, and integrity of the 
isolated total RNA were determined by spectrophotometric analysis 
and native 1% agarose gel electrophoresis. Reverse transcription 
(complementary DNA synthesis) and real-time polymerase chain 
reaction (PCR) experiments were performed on a 7500 Real-Time 
PCR System (Applied Biosystems, Foster City, CA, USA). Cu/Zn 
SOD and Mn SOD gene expression [messenger RNA (mRNA)] 
were measured using TaqManTM Gene Expression Assays (primer 
sequences available upon request) according to the manufacturer’s 
instructions (Applied Biosystems). Gene expression data were 
calculated as follows: Normalized Cu/Zn SOD mRNA=Cu/Zn 
SOD mRNA/ β-actin mRNA; normalized Mn SOD mRNA=Mn 
SOD mRNA/β-actin mRNA. Negative controls for reverse 
transcription (without reverse transcriptase) and for real-time PCR 
(no complementary DNA) were included in all experiments.
Statistical analysis
The Shapiro-Wilk test was used to examine the data distributions 
of the examined variables. Data are shown as arithmetic mean ± 
standard deviation for normally distributed variables. Data that 
achieved a Gaussian distribution after logarithmic transformation 
are presented as geometric mean [95% confidence intervals (CIs)] 
(19). Skewed data are presented as medians (interquartile range). 
Normal and log-normal continuous variables were compared with 
Student’s t-test. Skewed data were compared with the Mann-
Whitney U test. Categorical variables are indicated as absolute 
frequencies and were compared using the chi-square test to 
prepare contingency tables. Pearson’s correlation analysis was 
used to estimate correlations between the parameters in the tested 
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populations. Data from the correlation analysis are presented as 
coefficients of correlation (r). If probability values (p) for r were 
<0.05, those variables were further tested in a multiple linear 
regression analysis. A multiple regression analysis was performed 
to estimate the independent contribution of clinical markers on Cu/
Zn SOD and Mn SOD gene expression. Data from the multiple 
regression models are presented as unstandardized coefficients 
(B), the 95% CIs, standardized coefficient (β), and the t-value. 
The F-ratio from the analysis of variance in the multiple regression 
analysis was used to determine whether the overall regression 
models provided a good data fit. Multicollinearity among the 
independent variables was also tested. Study power was calculated 
using the post-hoc Statistical Power Calculator for Multiple 
Regression (20). Statistical analyses were performed using SPSS 
version 22 software (SPSS Inc., Chicago, IL, USA). A p-value 
<0.05 was considered significant.
RESULTS
The general characteristics of the study groups are presented in 
Table 1. As expected, significant differences were detected in 
all parameters between the groups except LDL-c concentration. 
Patients undergoing hemodialysis were older and had a lower 
body mass index than the controls. In addition, total protein and 
HDL-c concentrations were lower in the patients than controls. 
In contrast, urea, creatinine, total cholesterol, triglycerides, and 
hsCRP concentrations were significantly higher in the patients 
than the controls (Table 1). A disruption in oxidative stress and 
antioxidative defense was apparent in the patients: TBARS and O2.- 
were significantly higher in patients compared with the controls, 
and TAS was significantly lower in the patients than the controls. 
These results indicate that the patients were in a state of oxidative 
stress. Normalized Cu/Zn SOD and Mn SOD mRNAs were higher 
in the patients than in the controls (Table 2). Associations between 
the parameters and SOD isoenzyme gene expression were tested 
using Pearson’s correlation analysis. Normalized Cu/Zn SOD 
mRNA was positively correlated with urea, creatinine, and O2.-. 
Negative correlations were noted between normalized Cu/Zn SOD 
mRNA and total protein, total cholesterol, HDL-c, LDL-c, and TAS. 
Normalized Mn SOD mRNA was negatively correlated with TAS 
and total protein but positively correlated with creatinine (Table 3). 
We conducted a multiple linear regression analysis to identify the 
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TABLE 1. Demographic and laboratory parameters in the tested populations
Control group Hemodialysis patients p 
N (male/female) 33 (15/18) 33 (19/14) 0.400#
Age, years 45.37±8.92 55.33±15.31 0.002
BMI, kg/m2 25.00±3.60 22.21±3.03 0.002
Total proteins, g/L 68.58±3.78 65.31±5.42 0.007
Urea, mmol/L 5.89±1.33 21.34±4.74 <0.001
Creatinine, µmol/L 87.15±10.95 972.12±171.58 <0.001
TC, mmol/L 5.07±0.92 4.61±0.92 0.046
HDL-c, mmol/L* 1.65±0.45 0.91±0.26 <0.001
LDL-c, mmol/L 3.09±0.76 2.74±0.80 0.080
TG, mmol/L* 1.24 (1.06-1.47) 1.74 (1.46-2.08) 0.006
HsCRP, mg/L** 1.10 (0.81-1.49) 2.46 (1.30-4.60) <0.001
Hemodialysis 
duration, days*
- 54.85 (36.06-83.40) -
BMI: body mass index; HDL-c: high-density lipoprotein cholesterol; HsCRP: high 
sensitivity C-reactive protein; LDL-c: low-density lipoprotein cholesterol; TC: 
total cholesterol; TG: triglycerides; *Log-normal distributed data are presented 
as geometric mean (95% confidence interval) and compared with the Student’s 
t-test after logarithmic transformation; **Skewed data are presented as median 
(interquartile range) and compared with the Mann-Whitney U test; #Categorical data 
are compared using the chi-square test for contingency tables
Continuous data are presented as arithmetic mean ± standrard deviation and compared 
with the Student’s t-test.
TABLE 2. Oxidative stress status and antioxidative defense parameters in the 
tested populations
Control group Hemodialysis patients p
TAS, µmol/L 1142.19±122.74 858.79±199.39 <0.001
TBARS, 
µmol/L*
0.43 (0.35-0.52) 0.98 (0.77-1.25) <0.001
O2.-, µmol/L 51.67±12.85 196.65±76.66 <0.001
Normalized Cu/
Zn SOD mRNA 
0.85±0.21 1.39±0.72 <0.001
Normalized Mn 
SOD mRNA 
1.01±0.22 1.25±0.45 0.011
Cu/Zn SOD: Cu/Zn superoxide dismutase; Mn SOD: Mn superoxide dismutase; 
mRNA: messenger RNA; O2.-: superoxide anion radical; TAS: total antioxidant 
status; TBARS: thiobarbituric acid-reacting substances; *Log-normal distributed data 
are presented as geometric mean (95% confidence interval) and compared with the 
Student’s t-test after logarithmic transformation
Data are presented as arithmetic mean ± standard deviation and compared with the 
Student’s t-test.
TABLE 3. Bivariate Pearson’s correlation analysis between Cu/Zn SOD and Mn 
SOD messenger RNA s and other clinical parameters
Normalized Cu/Zn 
SOD mRNA
Normalized Mn SOD 
mRNA
r p r p
Age, years -0.023 0.865 0.094 0.477
LogBMI, kg/m2 -0.124 0.357 0.033 0.795
Total proteins, g/L -0.265 0.046 -0.268 0.040
Urea, mmol/L 0.382 0.003 0.184 0.167
Creatinine, µmol/L 0.484 <0.001 0.318 0.014
TC, mmol/L -0.289 0.026 -0.162 0.219
LogHDL-c, mmol/L -0.368 0.005 -0.234 0.079
LDL-c, mmol/L -0.319 0.016 -0.251 0.063
LogTG, mmol/L 0.154 0.244 0.070 0.599
TAS, µmol/L -0.512 <0.001 -0.424 0.001
LogTBARS, µmol/L 0.043 0.747 0.017 0.899
O2.-, µmol/L 0.374 0.045 0.153 0.253
BMI: body mass index; Cu/Zn SOD: Cu/Zn-superoxide dismutase; HDL-c: high-
density lipoprotein cholesterol; HsCRP: high sensitivity C-reactive protein; LDL-c: 
low-density lipoprotein cholesterol; Mn SOD: Mn superoxide dismutase; mRNA: 
messenger RNA; O2.-: superoxide anion radical; TAS: total antioxidant status; TBARS: 
thiobarbituric acid-reacting substances; TC: total cholesterol; TG: triglycerides
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parameters independently associated with normalized Cu/Zn SOD 
and Mn SOD mRNAs. Independent variables that were correlated 
with normalized Cu/Zn SOD mRNA in the Pearson’s correlation 
analysis with a p<0.05 (Table 3) were grouped into model 1. 
These independent variables (total protein, creatinine, HDL-c, 
LDL-c, TAS, and O2.-) determined in serum significantly predicted 
normalized Cu/Zn SOD mRNA in peripheral blood mononuclear 
cells [F(6.48)=5.249, p<0.001)]. This result also demonstrated 
that model 1 was a good fit for the data. An adjusted R2 of 0.339 
for model 1 demonstrated that 33.9% of the variation in the 
normalized Cu/Zn SOD mRNA in peripheral blood mononuclear 
cells was explained by model 1. Of all parameters, only TAS 
was independently associated with a decrease in normalized Cu/
Zn SOD mRNA (β=-0.311, p=0.038) (Table 4). Urea and total 
cholesterol were excluded from model 1 due to multicollinearity. 
The independent variables that correlated with normalized Mn SOD 
mRNA in Pearson’s correlation analysis at p<0.05 (Table 3) were 
grouped into model 2. These independent variables (total protein, 
creatinine, and TAS) determined in serum significantly predicted 
normalized Mn SOD mRNA in peripheral blood mononuclear cells 
[F(3.52)=5.879, p=0.002]. Model 2 was also a good fit for the data. 
An adjusted R2 of 0.210 demonstrated that 21% of the variation 
in Mn SOD mRNA could be explained by model 2. As shown for 
model 1, only TAS was independently associated with a decrease 
in normalized Mn SOD mRNA (β=-0.374, p=0.018) (Table 5). The 
post-hoc calculated statistical power values for the study from the 
multiple linear regression analysis were 0.99 and 0.98 according to 
models 1 and 2, respectively.
DISCUSSION
Many factors are involved in the pathogenesis of oxidative stress 
in patients with chronic kidney disease receiving hemodialysis. 
Oxidative stress in patients with chronic kidney disease occurs 
before patients begin hemodialysis (5,21). Besides metabolic and 
functional organ disorders that occur in chronic kidney disease, 
hemodialysis itself contributes to enhance oxidative stress, through 
production of ROS (especially O2.-), such as when leukocytes 
contact the hemodialysis membrane. A decrease in blood 
antioxidants, which occurs because of their consumption during 
ROS neutralization and loss through the dialyzer membrane, 
additionally contribute to increase oxidative stress (10,22). 
TABLE 4. Multiple regression analysis for independent association of examined parameters with Cu/Zn SOD 
gene expression levels
Dependent variable normalized Cu/Zn SOD mRNA F(6.48)=5.249, p<0.001
R2=0.415
Adjusted R2=0.339
Predictors
Unstandardized Standardized coefficient
B 95% CI β t p
Total proteins, g/L -1.009 (-2.369)-0.351 -0.173 -1.492 0.142
Creatinine, µmol/L 0.425 (-0.205)-1.055 0.347 1.356 0.182
LogHDL-c, mmol/L 0.588 (-0.698)-1.875 0.176 0.919 0.362
LDL-c, mmol/L -1.630 (-3.417)-0.157 -0.227 -1.834 0.073
TAS, µmol/L -0.788 (-1.532)-(-0.044) -0.311 -2.129 0.038
O2.-, µmol/L 0.036 (-0.169)-0.242 0.059 0.355 0.724
Cu/Zn SOD: Cu/Zn superoxide dismutase; HDL-c: high-density lipoprotein cholesterol; LDL-c: low-density 
lipoprotein cholesterol; Mn SOD: Mn superoxide dismutase; mRNA: messenger RNA; O2.-: superoxide anion radical; 
TAS: total antioxidant status; Model 1: total protein, creatinine, HDL-c, LDL-c, TAS and O2.- 
TABLE 5. Multiple regression analysis for the independent associations between the examined parameters and 
Mn superoxide dismutase gene expression levels
Dependent variable normalized Mn SOD mRNA F(3.52)=5.879, p=0.002
R2=0.253
Adjusted R2=0.210
Predictors
Unstandardized Standardized coefficient
B 95% CI β t p
Total proteins, g/L -0.161 (-0.853)-0.531 -0.057 -0.466 0.643
Creatinine, µmol/L 0.062 (-0.179)-0.303 0.072 0.515 0.608
TAS, µmol/L -0.611 (-1.114)-(-0.108) -0.374 -2.435 0.018
CI: confidence interval; Mn SOD: Mn superoxide dismutase; mRNA: messenger RNA; TAS: total antioxidant status; 
Model 2: total proteins, creatinine, TAS
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According to our results, the patients were in a state of oxidative 
stress (Table 2). TBARS and O2.- were significantly higher and 
TAS was significantly lower in patients than in controls (Table 
2). Furthermore, TAS was negatively correlated with TBARS 
and O2.- (r=-0.328, p=0.008 and r=-0.515, p<0.001, respectively). 
TBARS and O2.-
 were positively correlated (r=0.328, p=0.008) 
(data not shown). Malondialdehyde, a component of TBARS, is 
the ultimate product of lipid peroxidation and an oxidative stress 
marker (10). An increase in malondialdehyde concentration 
indicates higher ROS production. Reduced elimination of ROS 
can be a consequence of higher TBARS production (10,23). In 
addition to very high reactivity, O2.- inhibits nitric oxide-dependent 
vasodilation, which could impair cardiovascular function leading 
to a high mortality rate in patients undergoing hemodialysis (24). 
TAS, which includes all non-enzymatic components in plasma 
(11), is an important parameter to assess the capacity of a biological 
system to prevent oxidative stress. As shown in Table 1, urea and 
creatinine were significantly higher in patients than in controls 
(p<0.001, for both), and total protein was significantly higher in 
controls than in patients (p=0.007). As most of TAS is comprised of 
protein (>50%) (11,16), it was expected that TAS would be lower 
in patients than in controls. Previous studies have shown that TAS 
is lower in patients before and after hemodialysis compared with 
controls (25,26). According to a study by Zargari and Sedighi (25) 
and in line with ours, a pronounced increase in TBARS and O2.-, a 
decrease in TAS, and their significant negative correlation indicate 
a significant burden and decrease in non-enzymatic antioxidant 
protection due to chronic exposure to ROS. Activated leukocytes 
provide a link between oxidative stress and inflammation (5,10). In 
Uremic syndrome, chronic activation of the immune system leads 
to continuous low-grade inflammation characterized by increased 
cytokines (tumor necrosis factor-α, interleukin-1, and interleukin-6) 
and CRP in the blood. The patients in our study were in a state of 
oxidative stress and had an hsCRP concentration of 2.46 mg/dL 
(95% CI 1.30-4.60 mg/dL), indicating low-grade inflammation. In 
addition, CRP is a potent stimulator of antioxidant enzyme gene 
expression in leukocytes. One of the main objectives of our study 
was to examine gene expression of SOD isoenzymes in peripheral 
blood mononuclear cells from patients receiving hemodialysis, 
to compare it with that from controls, and to determine which 
oxidative stress status parameters regulated expression of their 
genes. Leukocytes are surrogate cells for an antioxidant enzyme 
gene expression analysis, not only because they are a source of 
ROS, but also because they are the target sites of the effects of 
ROS (4,9,27). During contact with the hemodialysis membrane, 
activated leukocytes release ROS and cytokines that further affect 
the leukocytes themselves and other cells with which they come 
into contact with. These events induce antioxidant enzyme gene 
expression (27,28). These results confirmed previous findings. 
Normalized Cu/Zn SOD and Mn SOD mRNAs were significantly 
higher in patients, who were in oxidative stress and low-grade 
inflammation states, than in controls (Table 2). Only a few studies 
have investigated SOD isoenzyme gene expression in leukocytes 
from patients undergoing hemodialysis (29,30) with conclusions 
similar to ours. However, the main cause for the induction of SOD 
genes remains unknown. Some authors (29,30) have hypothesized 
that chronic oxidative stress and inflammation in Uremic syndrome 
contributes to increase induction of SOD isoenzyme genes due to 
high CRP and O2.- as positive modulators of anti-oxidative enzyme 
transcriptional processes in cells. O2.- was positively correlated 
only with normalized Cu/Zn SOD mRNA (Table 3). Moreover, 
we were unable to establish any significant correlation between 
normalized SOD isoenzyme mRNAs and hsCRP. Although 
patients on hemodialysis were older than the controls (Table 1), we 
assumed no significant impact of age on normalized Cu/Zn SOD 
or Mn SOD mRNAs because there was no significant correlation 
between normalized SOD isoenzyme mRNAs and age (Table 3). In 
addition, no significant differences in normalized SOD isoenzyme 
mRNAs were observed when compared between age tertiles 
separately in patients and controls (data not presented).
According to our results, elevated Cu/Zn SOD and Mn SOD 
gene expression in peripheral blood mononuclear cells from the 
patients (Table 2) probably indicates a defense mechanism against 
oxidative stress and the consumption of plasma antioxidants. 
Schettler et al. (27,30) concluded similarly. They assumed that 
induction of SOD isoenzyme gene expression occurs in other 
organs as well, but there is insufficient evidence for this claim in the 
literature. Furthermore, our results show significant associations 
between plasma antioxidants and Cu/Zn SOD and Mn SOD gene 
expression in peripheral blood mononuclear cells. Normalized Cu/
Zn SOD mRNA was negatively correlated with TAS but positively 
correlated with O2.-. Normalized Mn SOD mRNA was negatively 
correlated with TAS (Table 3). As TAS decreased, Cu/Zn SOD and 
Mn SOD mRNAs increased, which acted as an adaptive mechanism 
to decrease antioxidants and increase oxidative stress. TAS was an 
independent predictor of normalized Cu/Zn SOD and Mn SOD 
mRNAs when tested by multiple linear regression analysis (β=-
0.311, p=0.038 and β=-0.374, p=0.018, respectively) (Table 4, 5). 
Model 1 significantly predicted normalized Cu/Zn SOD mRNA in 
peripheral blood mononuclear cells [F(6.48)=5.249, p<0.001] and 
explained 33.9% of the variation in its levels. Model 2 significantly 
predicted normalized Mn SOD mRNA [F(3.52)=5.879, p=0.002] 
and explained 21% of the variation in its levels. O2.-
 in the blood 
failed to independently predict normalized Cu/Zn SOD mRNA 
(Table 4). This is the first study to demonstrate independent 
associations between SOD isoenzyme gene expression in peripheral 
blood mononuclear cells and TAS in blood. Two limitations 
of this study should be mentioned. First, we only had access to 
a small number of controls and patients; hence, our conclusions 
need to be confirmed in a larger study. Second, SOD isoenzyme 
activities and concentrations were not determined. As variations 
in gene expression do not necessarily reflect protein abundance 
and activity, this limitation remains to be explored. Patients 
undergoing hemodialysis with chronic kidney disease were in 
a state of increased oxidative stress. Higher O2.- combined with 
exhaustion of non-enzymatic antioxidative defenses (as shown by 
the decreased TAS values) are likely to be key inducers of Cu/Zn 
SOD and Mn SOD genes in peripheral blood mononuclear cells. 
Only TAS was an independent predictor of SOD isoenzyme gene 
expression in peripheral blood mononuclear cells.
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